Skip to main content
PepStack
Blutwerte · Marker

hsCRP

High-Sensitivity CRP · hs-CRP · C-Reaktives Protein hochsensitiv

Entzündungsmarker
Einheit:
mg/L

hsCRP quantifies the concentration of C-reactive protein in the blood, reflecting low-grade systemic inflammation.

Reference Ranges

Reference
0–3mg/L
0
1
3
LowNormalHigh
Reference
Optimal
Unit · mg/L

hsCRP levels >3 mg/L are considered high risk for cardiovascular events. Sex-specific differences may exist.

Overview

Übersicht

High-sensitivity C-reactive protein (hsCRP) is a refined version of the C-reactive protein test that measures low levels of CRP in the blood. CRP is an acute-phase protein produced by the liver in response to inflammation. The hsCRP test is sensitive enough to detect lower levels of inflammation that are associated with cardiovascular risk. Clinically, hsCRP is a significant marker for assessing the risk of cardiovascular diseases, particularly in individuals without known atherosclerotic cardiovascular disease (ASCVD). Researchers have found that elevated hsCRP levels are associated with an increased risk of major adverse cardiovascular events (MACE), cardiovascular death, and all-cause mortality. In the context of athletic performance and biohacking, hsCRP can be used to monitor systemic inflammation, which may affect recovery and overall health. Lower hsCRP levels are generally desirable for longevity and optimal health. However, researchers observed that hsCRP levels can be influenced by various factors, including acute infections, chronic inflammatory conditions, and lifestyle factors such as smoking and obesity. It is important to consider these confounders when interpreting hsCRP levels. The test does not require fasting, and while it is not highly time-of-day sensitive, consistent timing for repeated measures is recommended for comparability.

Klinische Bedeutung

Elevated hsCRP levels indicate increased inflammation and are associated with a higher risk of cardiovascular events. Lower levels suggest a lower risk of such events.

Dynamics

Trend Interpretation

Rising Values

Progressively rising hsCRP values suggest worsening inflammation and increased cardiovascular risk. Retest in 4 weeks if outside optimal range.

Falling Values

Progressively falling values suggest reduced inflammation and potentially lower cardiovascular risk.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Acute infection
  • Chronic inflammatory diseases
  • Obesity
  • Smoking
  • Sedentary lifestyle
  • High-stress levels
Cause

Low Levels

  • Anti-inflammatory medication use
  • Regular physical activity
  • Healthy weight
  • Non-smoking status
Protocol

How to Optimize

Lever

Lifestyle

  • Regular physical activity
  • Stress management techniques
  • Smoking cessation
Lever

Nutrition

  • Anti-inflammatory diet
  • High intake of fruits and vegetables
Lever

Supplementation

  • Omega-3 fatty acids
  • Curcumin

Note:

Consult a healthcare provider before starting any new supplement regimen.

Testing Guidelines

✓Fasting Not Required
✓Not Time-Sensitive

Draw at the same time of day for consistency.

Testing Frequency

Annually for cardiovascular risk assessment, more frequently if monitoring inflammation.

Interfering Factors

  • Recent infection
  • Intense physical activity
  • Chronic inflammatory conditions

Related Peptides & Hormones

Interleukin 6

Correlated with

hormone or peptide

Open Research Questions

Current research suggests that sex-specific reference intervals for hsCRP are understudied, potentially leading to underdiagnosis in women. Researchers have not yet established optimal hsCRP targets for different populations, particularly in primary prevention settings. Additionally, clinical questions remain unanswered regarding the confounding effects of comorbidities and lifestyle factors on hsCRP levels and their implications for cardiovascular risk stratification.

48 Research Publications

1,269

Total Citations

24

Human/RCT

7.8

Avg. Influence

2025

Latest

Sort
Filter
#01

From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection.

ReviewInfluence29.0
806
This study discussed hsCRP's role in predicting vascular risk and its relationship with inflammation. Researchers observed that hsCRP levels are significant predictors of cardiovascular risk, especially in the context of statin therapy.
View on PubMed
#02

Role of High-Sensitivity C-reactive Protein (Hs-CRP) in Non-communicable Diseases: A Review.

ReviewInfluence6.0
121
This review discussed the role of high-sensitivity C-reactive protein (hsCRP) in non-communicable diseases such as cardiovascular diseases and diabetes. Researchers highlighted hsCRP's potential as a reliable biomarker for predicting disease risk and the impact of lifestyle modifications on reducing hsCRP levels.
View on PubMed
#03

PCSK9 inhibition and inflammation: A narrative review.

Ruscica Massimiliano, et al. · Atherosclerosis · 2019

ReviewInfluence4.0
114
This narrative review examined the relationship between high-sensitivity C-reactive protein (hs-CRP) and inflammation in atherosclerotic cardiovascular disease. Researchers noted that while PCSK9 inhibitors effectively lower LDL-C, they do not significantly affect hs-CRP levels, indicating the importance of hs-CRP in assessing residual cardiovascular risk.

Key findings

  1. 01Researchers found that high levels of hs-CRP, a marker of inflammation, are linked to a greater risk of cardiovascular events, even in patients with low LDL cholesterol.
  2. 02They observed that PCSK9 inhibitors, which effectively lower LDL cholesterol, do not significantly change hs-CRP levels.
  3. 03The studies indicated that patients with elevated hs-CRP may still face residual risk for cardiovascular disease despite receiving standard cholesterol-lowering therapies.
View on PubMed
#04

The Use of High Sensitivity C-Reactive Protein in Cardiovascular Disease Detection.

ReviewInfluence4.0
84
This review discussed the use of high-sensitivity C-reactive protein (hsCRP) in detecting cardiovascular diseases. Researchers highlighted its role as a biomarker of inflammation and its potential utility in diagnosing acute cardiovascular events, emphasizing the need for awareness of its association with cardiovascular risk.
View on PubMed
#05

Inflammation in atherothrombosis: how to use high-sensitivity C-reactive protein (hsCRP) in clinical practice.

ReviewInfluence2.0
42
Researchers found that hsCRP is a valuable biomarker for predicting cardiovascular risk and guiding treatment decisions. They highlighted the importance of measuring hsCRP alongside traditional risk factors and noted that lifestyle changes and medications can help lower hsCRP levels.
View on PubMed
#06

C-reactive protein and cardiovascular risk in the general population.

UnknownInfluence2.0
41
This population-based study evaluated hsCRP levels in nearly 450,000 individuals without known cardiovascular disease. Researchers found that higher hsCRP levels were associated with increased risks of major cardiovascular events and mortality, confirming its predictive value.
View on PubMed
#07

Cholesterol, lipoproteins, high-sensitivity c-reactive protein, and other risk factors for atherosclerosis.

Review
33
This study examined the role of traditional and emerging risk factors for coronary heart disease, including high-sensitivity C-reactive protein (hsCRP). Researchers found that new biological and genetic risk factors are reshaping the understanding of heart disease and improving risk assessment tools.
View on PubMed
#08

Genome-wide association study of high-sensitivity C-reactive protein, D-dimer, and interleukin-6 levels in multiethnic HIV+ cohorts.

Human
9
This study aimed to identify genetic factors associated with hsCRP levels in people living with HIV. Researchers found several genetic loci linked to elevated hsCRP, D-dimer, and interleukin-6 levels. The findings suggest that genetics may contribute to chronic inflammation in this population, highlighting potential targets for intervention.
View on PubMed
#09

Salivary High-Sensitivity C-Reactive Protein and Its Clinical Relevance in Modern Medicine: A Comprehensive Review.

Review
5
This comprehensive review focused on salivary high-sensitivity C-reactive protein (hsCRP) as a non-invasive biomarker for chronic diseases. Researchers discussed its potential advantages over blood-based assays and emphasized the need for further validation and integration into clinical practice.
View on PubMed
#10

Association Between High-Sensitivity C-Reactive Protein (hs-CRP) Levels With Lipids and Micronutrients.

Human
3
Researchers found significant correlations between elevated hs-CRP levels and various lipid and micronutrient markers in a cohort of individuals. The study highlighted that abnormal lipid levels and certain micronutrient deficiencies could contribute to increased hs-CRP, indicating a complex interplay between inflammation and metabolic health.
View on PubMed

Clinical Trials (6)

6

Total Trials

367

Total Enrolled

Fasting-mimicking Diet and Periodontitis (FMD)

NCT06074861COMPLETED
Sponsor

Universitat Internacional de Catalunya

Enrollment

28

Started

2023

Primary outcome

High-sensitivity C-reactive protein (hs-CRP) values in serum

Periodontal Disease, AVDC Stage 3Periodontal Disease, AVDC Stage 4Periodontitis

COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE)

NCT06062277Phase 2UNKNOWN
Sponsor

University College Dublin

Enrollment

91

Started

2023

Primary outcome

Change in hsCRP level

Ischemic StrokeAtherosclerosis

Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population

NCT05529693COMPLETED
Sponsor

Chr Hansen

Enrollment

42

Started

2022

Primary outcome

hs-CRP

Inflammation

Effect of Energy Restriction and Exercise for Knee Osteoarthritis

Sponsor

University of Bath

Enrollment

32

Started

2022

Primary outcome

Change in hsCRP

Knee Osteoarthritis

Phase 2a Study to Evaluate the Safety and Efficacy of PH100 Tablet in T2DM Patients With Recent Cardiovascular

NCT04141241Phase 2COMPLETED
Sponsor

Bota Bio Co., Ltd.

Enrollment

82

Started

2016

Primary outcome

hs-CRP (high-sensitivity C-reactive protein)

Type 2 Diabetes Mellitus With Circulatory Complciation

Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease

NCT00479986Phase 4COMPLETED
Sponsor

IKFE Institute for Clinical Research and Development

Enrollment

92

Started

2005

Primary outcome

Short-term effect of Pioglitazone on Markers of vascular risk (MMP-9, hsCRP, monocyte activation)

Type 2 Diabetes MellitusCardiovascular Disease

Publication Trend

Research publications about hsCRP over time

10total
1
'12
1
'15
1
'16
1
'22
4
'24
2
'25

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer